Ranitidine (Sandoz Inc.)
Welcome to the PulseAid listing for the Ranitidine drug offered from Sandoz Inc.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc. |
| NON-PROPRIETARY NAME: | Ranitidine |
| SUBSTANCE NAME: | RANITIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | SYRUP |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-10-25 |
| END MARKETING DATE: | 2020-10-25 |
Ranitidine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ranitidine from Sandoz Inc. |
| LABELER NAME: | Sandoz Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/mL) |
| START MARKETING DATE: | 2011-10-25 |
| END MARKETING DATE: | 2020-10-25 |
| PRODUCT ID: | 0781-6087_c08234ca-78f9-4e97-a4d4-0fbc4fd45bd1 |
| PRODUCT NDC: | 0781-6087 |
| APPLICATION NUMBER: | ANDA090054 |
Other RANITIDINE Pharmaceutical Manufacturers / Labelers:
